Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic Neuralgia
Recruiting
Observational Study
Postherpetic Neuralgia
Neuropathic Pain
Herpes Zoster
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- Diskapi Teaching and Research Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This observational study aims to compare the effectiveness of ultrasound-guided erector spinae plane (ESP) block and transcutaneous radiofrequency (RF) treatment in patients with postherpetic neuralgia. Pain intensity and neuropathic pain characteristics will be evaluated using the Visual Analog Scale (VAS) and the Self-Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) score.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Diagnosis of postherpetic neuralgia involving cervical, thoracic, or lumbar regions
Age between 18 and 80 years
Persistent pain despite conservative treatment
Baseline VAS score \> 5
Exclusion Criteria:
Ophthalmic or extremity postherpetic neuralgia
Allergy to local anesth…
Contacts